Warner Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 9.01 M
as on 09-07-2024
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 0.71 M
as on 09-07-2024
- Satisfied Charges ₹ 6.15 Cr
as on 09-07-2024
About Warner Laboratories
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.01 M.
The company currently has active open charges totaling ₹0.71 M. The company has closed loans amounting to ₹6.15 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhaskara Setti, Umamaheswara Kotte, Venkata Naravula, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100TG1994PTC018034
- Company No.
018034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1994
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Warner Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskara Setti  | Director | 10-May-2010 | Current |
| Umamaheswara Kotte | Additional Director | 14-Aug-2009 | Current |
| Venkata Naravula | Director | 10-May-2010 | Current |
| Sri Kolli | Director | 05-Jul-2010 | Current |
Financial Performance of Warner Laboratories.
Enhance accessibility to Warner Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Warner Laboratories?
Unlock access to Warner Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 22 Mar 1995 | ₹0.71 M | Open |
State Bank Of India Creation Date: 28 May 2010 | ₹3.10 Cr | Satisfied |
Andhra Bank Creation Date: 13 Oct 2007 | ₹0.50 M | Satisfied |
How Many Employees Work at Warner Laboratories?
Unlock and access historical data on people associated with Warner Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Warner Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Warner Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
